Riva Health, Inc.

Vital Labs, Inc. is a US-based company focused on transforming cardiovascular healthcare through innovative digital health solutions that enhance patient engagement and treatment management. Founded in 2013 and headquartered in Denver, US, Vital Labs, Inc. specializes in cardiovascular health management.

The company has completed 3 deals to date, with its most recent transaction occurring on December 30, 2020. The firm successfully raised USD 12. 52 mn in Series A funding led by Menlo Ventures, which included investments from CU Healthcare Innovation Fund, True Ventures, and UCHealth. The CEO and co-founder, Dag Kittlaus, has a history of founding technology-driven companies.

Vital Labs, Inc. specializes in innovative solutions aimed at transforming cardiovascular healthcare. Their core offerings include advanced digital health platforms that leverage technology to monitor and manage heart health, specifically targeting conditions such as hypertension and heart disease. These platforms provide real-time health data, personalized insights, and tailored interventions, facilitating improved patient outcomes.

The company serves a diverse client base, including healthcare providers, insurance companies, and direct consumers, predominantly in North America and Europe. Vital Labs’ solutions empower healthcare professionals with tools to enhance patient engagement and adherence to treatment plans, addressing critical challenges in cardiovascular care management. Vital Labs, Inc. generates revenue through a subscription-based model, primarily targeting healthcare providers and payers who integrate the company’s digital health solutions into their offerings.

This model allows clients to access a suite of services designed to support cardiovascular health management. Transactions typically involve annual or monthly licensing agreements granting access to Vital Labs’ platforms, along with ongoing support and updates. While specific pricing plans for individual products are not disclosed, this structure indicates a focus on long-term partnerships with healthcare institutions, facilitating a steady revenue stream. The company’s flagship products serve as integral components of these agreements, streamlining the delivery of cardiovascular care and improving overall healthcare efficiency.

In December 2020, Vital Labs, Inc. raised USD 12. 52 mn in Series A funding, led by Menlo Ventures, to support its expansion initiatives. The company plans to design and launch new digital health products aimed at enhancing cardiovascular care, with specific release dates to be announced.

Additionally, Vital Labs is targeting expansion into new geographic markets, including Europe and Asia, by 2023, to broaden its reach and impact. The funding secured will enable the company to accelerate these initiatives, enhancing its product offerings and market presence.